BridgeBio Pharma to Present Acoramidis Data at HFSA Meeting

BridgeBio Pharma announced that it will present new acoramidis data, including independent comparative real-world EHR data, at the HFSA Annual Scientific Meeting 2026. The presentation will include one oral presentation and three rapid-fire sessions.